• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年初级保健就诊者的多种药物治疗变化发生在开处方者层面。

Variation of polypharmacy in older primary care attenders occurs at prescriber level.

机构信息

Healthcare Statistics Unit, National Clinical Research Centre, 3rd floor, MMA House, 124, Jalan Pahang, 53000, Kuala Lumpur, Malaysia.

Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.

出版信息

BMC Geriatr. 2018 Feb 23;18(1):59. doi: 10.1186/s12877-018-0750-2.

DOI:10.1186/s12877-018-0750-2
PMID:29471806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5824493/
Abstract

BACKGROUND

Polypharmacy is particularly important in older persons as they are more likely to experience adverse events compared to the rest of the population. Despite the relevance, there is a lack of studies on the possible association of patient, prescriber and practice characteristics with polypharmacy. Thus, the aim of this study was to determine the rate of polypharmacy among older persons attending public and private primary care clinics, and its association with patient, prescriber and practice characteristics.

METHODS

We used data from The National Medical Care Survey (NMCS), a national cross-sectional survey of patients' visits to primary care clinics in Malaysia. A weighted total of 22,832 encounters of patients aged ≥65 years were analysed. Polypharmacy was defined as concomitant use of five medications and above. Multilevel logistic regression was performed to examine the association of polypharmacy with patient, prescriber and practice characteristics.

RESULTS

A total of 20.3% of the older primary care attenders experienced polypharmacy (26.7%% in public and 11.0% in private practice). The adjusted odds ratio (OR) of polypharmacy were 6.37 times greater in public practices. Polypharmacy was associated with patients of female gender (OR 1.49), primary education level (OR 1.61) and multimorbidity (OR 14.21). The variation in rate of polypharmacy was mainly found at prescriber level.

CONCLUSION

Polypharmacy is common among older persons visiting primary care practices. Given the possible adverse outcomes, interventions to reduce the burden of polypharmacy are best to be directed at individual prescribers.

摘要

背景

与其他人群相比,老年人更有可能经历不良反应,因此,多药治疗在老年人中尤为重要。尽管多药治疗很重要,但目前关于患者、医生和实践特征与多药治疗之间可能存在关联的研究较少。因此,本研究旨在确定在参加公立和私立初级保健诊所的老年人中多药治疗的发生率,并探讨其与患者、医生和实践特征的关系。

方法

我们使用了来自马来西亚全国医疗保健调查(NMCS)的数据,该调查是对初级保健诊所患者就诊情况的全国性横断面调查。对 22832 名年龄≥65 岁的患者进行了加权分析。多药治疗定义为同时使用五种及以上药物。采用多水平逻辑回归分析多药治疗与患者、医生和实践特征的关系。

结果

共有 20.3%的老年初级保健就诊者经历了多药治疗(公立诊所为 26.7%,私立诊所为 11.0%)。在公立诊所中,多药治疗的调整后比值比(OR)是 6.37 倍。多药治疗与女性(OR 1.49)、小学教育程度(OR 1.61)和多种合并症(OR 14.21)的患者相关。多药治疗率的差异主要存在于医生层面。

结论

多药治疗在老年患者中很常见。鉴于多药治疗可能产生的不良后果,减少多药治疗负担的干预措施最好针对个体医生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca28/5824493/c595a86bab39/12877_2018_750_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca28/5824493/c94c5d4698c8/12877_2018_750_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca28/5824493/0eee77664443/12877_2018_750_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca28/5824493/c595a86bab39/12877_2018_750_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca28/5824493/c94c5d4698c8/12877_2018_750_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca28/5824493/0eee77664443/12877_2018_750_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca28/5824493/c595a86bab39/12877_2018_750_Fig3_HTML.jpg

相似文献

1
Variation of polypharmacy in older primary care attenders occurs at prescriber level.老年初级保健就诊者的多种药物治疗变化发生在开处方者层面。
BMC Geriatr. 2018 Feb 23;18(1):59. doi: 10.1186/s12877-018-0750-2.
2
Association of potentially inappropriate medication use with patient and prescriber characteristics in Medicare Part D.医疗保险处方药中潜在不适当用药与患者和处方医师特征的相关性。
Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):728-34. doi: 10.1002/pds.3431. Epub 2013 Mar 14.
3
High-risk prescribing in an Irish primary care population: trends and variation.爱尔兰初级保健人群中的高风险处方:趋势与差异
Br J Clin Pharmacol. 2017 Dec;83(12):2821-2830. doi: 10.1111/bcp.13373. Epub 2017 Aug 16.
4
Inter-practice variation in polypharmacy prevalence amongst older patients in primary care.基层医疗中老年患者多重用药患病率的诊所间差异。
Pharmacoepidemiol Drug Saf. 2016 Sep;25(9):1033-41. doi: 10.1002/pds.4016. Epub 2016 May 2.
5
Health profiles of foreigners attending primary care clinics in Malaysia.在马来西亚初级保健诊所就诊的外国人的健康状况
BMC Health Serv Res. 2016 Jun 14;16:197. doi: 10.1186/s12913-016-1444-0.
6
Using electronic medical record data to characterize the level of medication use by age-groups in a network of primary care clinics.利用电子病历数据来描述初级保健诊所网络中各年龄组的用药水平。
J Prim Care Community Health. 2013 Oct;4(4):286-93. doi: 10.1177/2150131913495243. Epub 2013 Jul 8.
7
Improvement happens: team-based primary care, an interview with Stuart Pollack.进步正在发生:基于团队的初级医疗保健,对斯图尔特·波拉克的一次访谈
J Gen Intern Med. 2015 Apr;30(4):521-8. doi: 10.1007/s11606-014-3119-z.
8
Health professional perspectives on the management of multimorbidity and polypharmacy for older patients in Australia.澳大利亚医疗专业人员对老年患者多重疾病和多重用药管理的看法。
Age Ageing. 2017 Mar 1;46(2):291-299. doi: 10.1093/ageing/afw200.
9
Improvement happens: an interview with Christine Sinsky, MD. Interview by Richard L. Kravitz.进步正在发生:对医学博士克里斯汀·辛斯基的访谈。采访者:理查德·L·克拉维茨。
J Gen Intern Med. 2010 May;25(5):474-7. doi: 10.1007/s11606-010-1281-5.
10
Improvement happens: an interview with Deeb Salem, MD and Brian Cohen, MD.进步正在发生:对迪布·塞勒姆医生和布莱恩·科恩医生的访谈。
J Gen Intern Med. 2012 Mar;27(3):381-5. doi: 10.1007/s11606-011-1947-7. Epub 2011 Dec 9.

引用本文的文献

1
Prevalence of polypharmacy in the older adult population within primary care in Portugal: a nationwide cross-sectional study.葡萄牙初级保健中老年人多重用药的患病率:一项全国性横断面研究。
Arch Med Sci. 2020 Mar 9;20(4):1118-1127. doi: 10.5114/aoms.2020.93537. eCollection 2024.
2
Defining, identifying and addressing problematic polypharmacy within multimorbidity in primary care: a scoping review.在初级保健中,针对多病共存患者中的问题性多种药物治疗进行定义、识别和处理:范围综述。
BMJ Open. 2024 May 24;14(5):e081698. doi: 10.1136/bmjopen-2023-081698.
3
Are there socioeconomic inequalities in polypharmacy among older people? A systematic review and meta-analysis.

本文引用的文献

1
Hospitalization in older patients due to adverse drug reactions -the need for a prediction tool.老年患者因药物不良反应而住院——对预测工具的需求。
Clin Interv Aging. 2016 May 2;11:497-505. doi: 10.2147/CIA.S99097. eCollection 2016.
2
Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study.与智障老年人多重用药和过度多重用药相关的因素与普通人群不同:一项全国性横断面观察研究。
BMJ Open. 2016 Apr 4;6(4):e010505. doi: 10.1136/bmjopen-2015-010505.
3
Defining polypharmacy in the elderly: a systematic review protocol.
老年人多重用药存在社会经济不平等现象吗?一项系统评价与荟萃分析。
BMC Geriatr. 2023 Mar 18;23(1):149. doi: 10.1186/s12877-023-03835-z.
4
Evaluating the impact of a polypharmacy Action Learning Sets tool on healthcare practitioners' confidence, perceptions and experiences of stopping inappropriate medicines.评估多药治疗行动学习工具对医疗保健从业者在停止使用不当药物方面的信心、认知和经验的影响。
BMC Med Educ. 2022 Jun 27;22(1):499. doi: 10.1186/s12909-022-03556-8.
5
Prevalence of polypharmacy in community-dwelling older adults from seven centres in five European countries: a cross-sectional study of DO-HEALTH.来自五个欧洲国家七个中心的社区居住老年人中多重用药的流行情况:DO-HEALTH 的一项横断面研究。
BMJ Open. 2022 Apr 29;12(4):e051881. doi: 10.1136/bmjopen-2021-051881.
6
Physicians' perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study.医生对公共初级保健诊所老年患者药物减量的认知障碍和促进因素:一项定性研究。
Int J Clin Pharm. 2022 Feb;44(1):201-213. doi: 10.1007/s11096-021-01336-w. Epub 2021 Oct 12.
7
Potentially inappropriate medications (PIMs): frequency and extent of GP-related variation in PIMs: a register-based cohort study.潜在不适当药物(PIMs):与全科医生相关的 PIM 变异的频率和程度:基于登记的队列研究。
BMJ Open. 2021 Jul 14;11(7):e046756. doi: 10.1136/bmjopen-2020-046756.
8
Irrational drug use and its associated factors at Debre Markos Referral Hospital's outpatient pharmacy in East Gojjam, Northwest Ethiopia.埃塞俄比亚西北部东戈贾姆德布雷马尔科斯转诊医院门诊药房的不合理用药及其相关因素
SAGE Open Med. 2021 Jun 12;9:20503121211025146. doi: 10.1177/20503121211025146. eCollection 2021.
9
Prevalence of Drug-Related Problems and Complementary and Alternative Medicine Use in Malaysia: A Systematic Review and Meta-Analysis of 37,249 Older Adults.马来西亚药物相关问题及补充与替代医学使用情况的患病率:对37249名老年人的系统评价和荟萃分析
Pharmaceuticals (Basel). 2021 Feb 25;14(3):187. doi: 10.3390/ph14030187.
10
The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population - Public Health Implications.新冠疫情与老年人群多重用药的双重负担——对公共卫生的影响
Ther Clin Risk Manag. 2020 Oct 20;16:1007-1022. doi: 10.2147/TCRM.S272908. eCollection 2020.
老年人多重用药的定义:一项系统评价方案。
BMJ Open. 2016 Mar 24;6(3):e010989. doi: 10.1136/bmjopen-2015-010989.
4
Medication Regimen Complexity and Number of Medications as Factors Associated With Unplanned Hospitalizations in Older People: A Population-based Cohort Study.药物治疗方案复杂性和用药数量作为老年人非计划性住院相关因素的一项基于人群的队列研究。
J Gerontol A Biol Sci Med Sci. 2016 Jun;71(6):831-7. doi: 10.1093/gerona/glv219. Epub 2015 Dec 26.
5
Medication Regimen Complexity and Polypharmacy as Factors Associated With All-Cause Mortality in Older People: A Population-Based Cohort Study.药物治疗方案复杂性和多重用药作为老年人全因死亡率相关因素:一项基于人群的队列研究。
Ann Pharmacother. 2016 Feb;50(2):89-95. doi: 10.1177/1060028015621071. Epub 2015 Dec 17.
6
Bad apples or spoiled barrels? Multilevel modelling analysis of variation in high-risk prescribing in Scotland between general practitioners and between the practices they work in.坏苹果还是变质桶?对苏格兰全科医生及其工作的诊所之间高风险处方差异的多层次建模分析。
BMJ Open. 2015 Nov 6;5(11):e008270. doi: 10.1136/bmjopen-2015-008270.
7
Polypharmacy cut-points in older people with cancer: how many medications are too many?老年癌症患者的多重用药切点:多少种药物算过多?
Support Care Cancer. 2016 Apr;24(4):1831-40. doi: 10.1007/s00520-015-2970-8. Epub 2015 Oct 9.
8
Geriatric polypharmacy in Taiwan.台湾地区的老年多重用药问题
J Formos Med Assoc. 2016 Nov;115(11):891-892. doi: 10.1016/j.jfma.2015.08.003. Epub 2015 Sep 28.
9
Challenges faced by primary care physicians when prescribing for patients with chronic diseases in a teaching hospital in Malaysia: a qualitative study.马来西亚一家教学医院中基层医疗医生在为慢性病患者开处方时面临的挑战:一项定性研究。
BMJ Open. 2015 Aug 27;5(8):e007817. doi: 10.1136/bmjopen-2015-007817.
10
Traditional and Complementary Medicine (TCM) among Study Population with Cardiovascular Risk; use and Substitution for Conventional Medicine in Pahang, Malaysia.马来西亚彭亨州心血管疾病风险研究人群中的传统医学与补充医学;传统药物的使用与替代情况
Med J Malaysia. 2015 Apr;70(2):86-92.